Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Brammer, Jonathan E  [Clear All Filters]
2016
Valdez, B.C., Li, Y., Murray, D., Brammer, J.E., Liu, Y., Hosing, C., Nieto, Y., Champlin, R.E., and Andersson, B.S. (2016). Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy.Oncotarget.
Gaballa, S., Saliba, R.M., Srour, S., Lu, G., Brammer, J.E., Shah, N., Bashir, Q., Patel, K., Bock, F., Parmar, S., et al. (2016). Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.Am J Hematol.
Gaballa, S., Ge, I., Fakih, R.El, Brammer, J.E., Kongtim, P., Tomuleasa, C., Wang, S.A., Lee, D., Petropoulos, D., Cao, K., et al. (2016). Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.Cancer.
Valdez, B.C., Brammer, J.E., Li, Y., Murray, D., Teo, E.C., Liu, Y., Hosing, C., Nieto, Y., Champlin, R.E., and Andersson, B.S. (2016). Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.Leuk Res47, 100-108.
Brammer, J.E., Khouri, I., Marin, D., Ledesma, C., Rondon, G., Ciurea, S.O., Nieto, Y., Champlin, R.E., Hosing, C., and Kebriaei, P. (2016). Stem cell transplantation outcomes in lymphoblastic lymphoma.Leuk Lymphoma1-6.